相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-L1 expression by tumor cell lines: A predictive marker in melanoma
Anne C. Knol et al.
EXPERIMENTAL DERMATOLOGY (2018)
The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma
Bianca Simon et al.
EXPERIMENTAL DERMATOLOGY (2018)
Driving cars to the clinic for solid tumors
Mauro Castellarin et al.
GENE THERAPY (2018)
Chimeric Antigen Receptors in Different Cell Types: New Vehicles Join the Race
Dennis C. Harrer et al.
HUMAN GENE THERAPY (2018)
Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
Robert Q. Le et al.
ONCOLOGIST (2018)
Perspectives on Chimeric Antigen Receptor T-Cell immunotherapy for Solid Tumors
Paris Kosti et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Influence of Invariant Natural Killer T Cells on Humoral Immunity to T-Dependent and -Independent Antigens
Mark L. Lang
FRONTIERS IN IMMUNOLOGY (2018)
Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
Benjamin J. Wolf et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma
Bianca Simon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CAR
Elise A. Chong et al.
BLOOD (2017)
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
Jiangtao Ren et al.
CLINICAL CANCER RESEARCH (2017)
The Flipside of the Power of Engineered T Cells: Observed and Potential Toxicities of Genetically Modified T Cells as Therapy
Felipe Bedoya et al.
MOLECULAR THERAPY (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Is autoimmunity the Achilles' heel of cancer immunotherapy?
Carl H. June et al.
NATURE MEDICINE (2017)
IN-DEPTH REVIEW: CHIMERIC ANTIGEN RECEPTOR T CELLS-BASED THERAPIES CAR T-cell therapy for lung cancer and malignant pleural mesothelioma
Masha Zeltsman et al.
TRANSLATIONAL RESEARCH (2017)
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
Juliane Gust et al.
CANCER DISCOVERY (2017)
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Levi J. Rupp et al.
SCIENTIFIC REPORTS (2017)
CAR T-Cell Therapy: Progress and Prospects
Olivia Wilkins et al.
HUMAN GENE THERAPY METHODS (2017)
Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor-Modified T Cells Engineered to Secrete Checkpoint Inhibitors
Si Li et al.
CLINICAL CANCER RESEARCH (2017)
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma
Dennis C. Harrer et al.
BMC CANCER (2017)
Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
Mark A. Exley et al.
CLINICAL CANCER RESEARCH (2017)
Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma
Ugur Uslu et al.
EXPERIMENTAL DERMATOLOGY (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo
Gengwen Tian et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
Marco Ruella et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Desmoplastic melanoma: an updated immunohistochemical analysis of 40 cases with a proposal for an additional panel of stains for diagnosis
Jose A. Plaza et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2016)
Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient
Aude G. Chapuis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model
Eloah Rabello Suarez et al.
ONCOTARGET (2016)
Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
Clifford J. Whatcott et al.
CLINICAL CANCER RESEARCH (2015)
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2015)
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
Ignazio Caruana et al.
NATURE MEDICINE (2015)
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
Andras Heczey et al.
BLOOD (2014)
Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cells
Alessandro Poggi et al.
IMMUNOLOGY LETTERS (2014)
Overcoming tumor-mediated immunosuppression
Hans Anton Schloesser et al.
IMMUNOTHERAPY (2014)
Optimal Management of Metastatic Melanoma: Current Strategies and Future Directions
Marta Batus et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2013)
Tumor-infiltrating Lymphocytes, Tumor Characteristics, and Recurrence in Patients With Early Breast Cancer
Seung Tae Kim et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
Tyler R. Simpson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
Cor H. J. Lamers et al.
MOLECULAR THERAPY (2013)
Inflammation-induced interstitial migration of effector CD4+ T cells is dependent on integrin αV
Michael G. Overstreet et al.
NATURE IMMUNOLOGY (2013)
Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
Helene Salmon et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Phenotypic and Functional Attributes of Lentivirus-modified CD19-specific Human CD8+ Central Memory T Cells Manufactured at Clinical Scale
Xiuli Wang et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Cellular Traction Stresses Increase with Increasing Metastatic Potential
Casey M. Kraning-Rush et al.
PLOS ONE (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
Edmund K. Moon et al.
CLINICAL CANCER RESEARCH (2011)
Prognostic value of tumor-infiltrating Foxp3+T-cell subpopulations in metastatic melanoma
Anne C. Knol et al.
EXPERIMENTAL DERMATOLOGY (2011)
CXCR3 ligands: redundant, collaborative and antagonistic functions
Joanna R. Groom et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
Omar S. Qureshi et al.
SCIENCE (2011)
Gene Signature in Melanoma Associated With Clinical Activity A Potential Clue to Unlock Cancer Immunotherapy
Thomas F. Gajewski et al.
CANCER JOURNAL (2010)
Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b
John A. Craddock et al.
JOURNAL OF IMMUNOTHERAPY (2010)
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
Antonio Di Stasi et al.
BLOOD (2009)
Activation of Host Wound Responses in Breast Cancer Microenvironment
Melissa A. Troester et al.
CLINICAL CANCER RESEARCH (2009)
The good and the bad of chemokines/chemokine receptors in melanoma
Ann Richmond et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
Noninvasive detection of therapeutic cytolytic T cells with F-18-FHBG PET in a patient with glioma
Shahriar S. Yaghoubi et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Immune modulation by melanoma-derived factors
Dan Ilkovitch et al.
EXPERIMENTAL DERMATOLOGY (2008)
Orchestrating the orchestrators: chemokines in control of T cell traffic
Shannon K. Bromley et al.
NATURE IMMUNOLOGY (2008)
A unique subset of CD4+CD25high Foxp3+ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
Michael H. Kershaw et al.
CLINICAL CANCER RESEARCH (2006)
Suppression of antitumor immunity by IL-10 and TGF-β-producing T cells infiltrating the growing tumor:: Influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells
Andrew G. Jarnicki et al.
JOURNAL OF IMMUNOLOGY (2006)
Adoptive immunotherapy for cancer: building on success
L Gattinoni et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
L Gattinoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Biology of desmoplastic melanoma: A case-control comparison with other melanomas
DP Livestro et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4+ T-regulatory cells and systemic collapse of antitumour immunity
N Seo et al.
IMMUNOLOGY (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Active movement of T cells away from a chemokine
MC Poznansky et al.
NATURE MEDICINE (2000)
分享论文
